← Eichor
Study identifier: NCT07160621 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Culturally Adapted Mobile Treatment of Chronic Pain in Adolescent Survivors of Pediatric Cancer: A Randomized Clinical Trial

Condition: Childhood Cancer Survivor · Chronic Pain  ·  Sponsor: St. Jude Children's Research Hospital

PhaseNA
Planned participants228
Who can joinAll sexes, 10 Years to 17 Years
Healthy volunteersNo

About this study

The purpose of the study is to determine if an adapted mobile cognitive behavioral therapy (CBT) app (WebMAP Onc) is more effective than standard pain education in reducing chronic pain and improving daily functioning in adolescent survivors of pediatric cancer. This randomized study led by St. Jude Children's Research Hospital will involve 228 participants (114 adolescent survivors and 114 caregivers) across four U.S. hospitals. Outcomes include pain reduction, improved function, and the role of social determinants of health. Assessments occur at baseline, post-treatment, and 3-month follow-up.

This description comes directly from the study's public registry record.

Talk to the study team

Tara Brinkman, PhD  ·  888-226-4343  ·  referralinfo@stjude.org

Tara Brinkman  ·  8662785833  ·  referralinfo@stjude.org

Always discuss trial participation with your own doctor first.

Locations (1)

St. Jude Children's Research HospitalMemphis, Tennessee, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07160621